Rheumatology Territory Business Manager, Hartford, CT
argenx
Summary
The Territory Business Manager (TBM) will drive demand generation through a focused approach on Rheumatology. The TBM will build trusted relationships with healthcare professionals, academic institutions, and specialty pharmacy and infusion providers to improve patient access and outcomes. Working in close partnership with internal and field-based colleagues, the TBM will leverage data-driven insights, customer engagement, and a patient-first mindset to deliver on business objectives within their assigned geography. This role requires a collaborative, entrepreneurial professional who thrives in a dynamic environment, embraces accountability, and continuously seeks innovative ways to create value for patients, providers, and argenx. The TBM will report to the Business Leader. This position covers Hartford, New Haven, CT and Springfield, MA markets.
Job description
Roles & Responsibilities
- Travel within assigned geography and occasionally beyond to engage key stakeholders and support business objectives
- Develop and execute strategic territory and account plans that leverage customer, market, and business insights to drive performance
- Demonstrate Innovation by identifying opportunities, challenging conventional approaches, and implementing creative solutions that improve customer engagement and patient outcomes
- Embrace Co-Creation by collaborating effectively with regional colleagues and cross-functional partners to achieve shared goals and deliver value across the healthcare ecosystem
- Build and maintain productive relationships with assigned healthcare professionals, affiliated staff, specialty pharmacy partners, and infusion providers
- Apply Excellence through effective utilization of data, market intelligence, and approved tools and resources to inform decision-making and maximize impact
- Consistently achieve and exceed sales objectives while maintaining the highest standards of integrity and compliance
- Submit account plans, customer interactions, and CRM activity accurately and on time
- Demonstrate Empowerment by taking ownership of business results, making sound decisions, and proactively addressing challenges and opportunities within the territory
- Practice Humility by actively listening to customers, patients, caregivers, and colleagues, valuing diverse perspectives, and continuously learning to better serve the community
- Adhere to all argenx compliance policies, guidelines, and approved promotional messaging
Skills & Competencies
- Strong ability to sell collaboratively across a complex healthcare landscape
- High level of clinical, product, market access, and business acumen
- Demonstrated problem-solving and critical thinking capabilities
- Ability to work effectively within a network of teams and cross-functional partnerships
- Results-oriented with a strong focus on execution and accountability
- Skilled at engaging customers in both in-person and virtual environments
- Demonstrates ownership, initiative, and sound judgment
- Passionate about serving patients and improving their treatment journey
- Deep understanding of market access dynamics, including specialty pharmacy and buy-and-bill environments
- Ability to leverage data and insights to guide decisions and optimize performance
- Growth mindset with receptiveness to feedback, continuous learning, and professional development
Education, Experience & Qualifications
- 5+ years of specialty/rare disease/biologics sales experience; significant, demonstrated Rheumatology experience strongly preferred
- Proven track record of consistent high sales performance and successful execution against business objectives
- Experience planning, organizing, and executing territory and account strategies
- Demonstrated ability to collaborate effectively with internal stakeholders and cross-functional teams
- Ability to adapt and thrive in a rapidly evolving environment
- Product launch experience preferred
- Demonstrated alignment with the argenx Cultural Pillars: Innovation, Co-Creation, Empowerment, Excellence, Humility
- B.S. or B.A. degree required
- Candidates must reside within the assigned market/territory
Requirements
- 5+ years of specialty/rare disease/biologics sales experience
- Significant, demonstrated Rheumatology experience strongly preferred
- Proven track record of consistent high sales performance and successful execution against business objectives
- Experience planning, organizing, and executing territory and account strategies
- Demonstrated ability to collaborate effectively with internal stakeholders and cross-functional teams
- Ability to adapt and thrive in a rapidly evolving environment
- Product launch experience preferred
- B.S. or B.A. degree required
- Candidates must reside within the assigned market/territory
Benefits
- Retirement savings plans
- Health benefits
- Short-term and long-term incentive programs
Company overview
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Founded in 2008 and headquartered in Amsterdam, Netherlands with major operations in Boston, Massachusetts, argenx is a commercial-stage, fully-integrated biopharma company developing a deep pipeline of differentiated antibody-based therapies. The company's core innovation engine is its Immunology Innovation Program (IIP), which partners with leading academic researchers to translate immunology breakthroughs into novel medicines. argenx has developed and commercialized VYVGART, the first approved FcRn blocker available in more than 30 countries for conditions like generalized myasthenia gravis (gMG), chronic inflammatory demyelinating polyneuropathy (CIDP), and immune thrombocytopenia (ITP). The company leverages its proprietary SIMPLE ANTIBODY™ platform technology based on llama immune systems to access novel disease biology targets, combined with antibody engineering technologies like NHANCE™ and ABDEG™ to enhance therapeutic properties. With over 1,500 employees globally and listed on both Euronext Brussels and Nasdaq, argenx maintains a robust pipeline including empasiprubart (C2 inhibitor) in Phase 3 trials and several earlier-stage experimental medicines targeting various autoimmune conditions.